Approval · Notice of Compliance 12091 · 2011
ABSTRAL: Notice of Compliance 12091
Issued February 17, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12091
- Date
- February 17, 2011
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- FENTANYL CITRATE 100 MCG per TAB
- FENTANYL CITRATE 200 MCG per TAB
- FENTANYL CITRATE 300 MCG per TAB
- FENTANYL CITRATE 400 MCG per TAB
- FENTANYL CITRATE 600 MCG per TAB
- FENTANYL CITRATE 800 MCG per TAB